VeriSee DR is a Taiwan and Thailand FDA-approved diagnostic software for diabetic retinopathy (DR).
It uses AI and assists healthcare professionals to analyze retinal images for signs of DR and outputs recommendation on referral to ophthalmologists. The analyzed results can be edited with additional annotations before exporting as a PDF file. VeriSee DR has a screening accuracy of 93%, which is comparable to ophthalmologists. It is an effective solution that can shorten the screening process, increase the volume of screenings, improve the accuracy and consistency of the results, reduce costs, and improve patient outcome.